Login

Christopher J. Schaber, CEO, Soligenix Inc 00:00:00

Share On Facebook Share On Twitter

Soligenix's (NASDAQ:SNGX) Breakthrough Therapies for Rare Diseases

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Founder turned investor now spending the majority of their time to seek the opportunities|Brian Ma,Founder and Managing Partner, Iterative VC
00:10:00
Investing in Greece: From Contrarian Bet to Mainstream Opportunity | Mr. Stelios Theodosiou, Managing Director,  H.I.G. Capital.
00:10:00
Affordable Funeral Assistance Plan for Up to Seven People
00:10:00
We help ambitious founders who actively seek to change the status|David Fialkow,Managing Director,General Catalyst
00:00:00
Dr. Richard Lipscombe, Managing Director, Proteomics International Laboratories Lt
00:10:00
"Growth vs. Value: Howard Marks Analyzes Shifts in the Investment Landscape with Investec"
00:10:00
ROCA Industry Achieves 75% EBITDA Growth in First Half of 2024 | Ionuț Bindea, CEO, ROCA Industry Holdingrock1 SA.
00:10:00
Canadian Funding Boost for Natural Resources and Exploration
00:10:00
Mondoro's Exploration Focus in Eastern Europe: Copper and Gold in Serbia and Bulgaria
00:10:00
CEO Malcolm Wilson Talks Freight State and GXO's Strategies in a High-Rate Environment | Malcolm Wilson - CEO of GXO Logistics
00:10:00
Precision medicine approach to drug development tailoring medical treatment to the individual genetic characteristics of patients|Thomas A Keuer,President,ARCA Biopharma Inc
00:10:00
"Robert F. Wallace on Managing Stanford's $35 Billion Investment Portfolio | Investment Conference 2024"

© 2017 - Neuhu+